Status:
COMPLETED
ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
Lead Sponsor:
Janssen-Cilag, S.A.
Conditions:
Schizophrenia
Bipolar Disorder
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to find out how well new treatment plans are followed by outpatients with major mental illnesses (schizophrenia, bipolar disorder, depression, personality disorder) and to...
Detailed Description
Compliance (which refers to how well one follows a prescribed medication or therapy) varies among all types of diseases, but it is generally low for those outpatients with major mental illness. This l...
Eligibility Criteria
Inclusion
- Outpatients diagnosed with schizophrenia, bipolar disorder or depression according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) classification characteristics who have been given a new therapy plan (that may include drug treatment for mental illness, visits to a mental health care worker, or other treatments such as non-medication type of treatments)
- Patients either scheduled for treatment in the next 3 months or already treated for the past 3 months
Exclusion
- Patients with psychiatry pathology other than Schizophrenia or schizoaffective disorder/ bipolar disease/major depression
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
2622 Patients enrolled
Trial Details
Trial ID
NCT00264069
Start Date
June 1 2005
End Date
June 1 2006
Last Update
May 19 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.